Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation

@article{Bastianelli2018PharmacodynamicsOC,
  title={Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation},
  author={C. Bastianelli and M. Farris and Elena Rosato and I. Brosens and G. Benagiano},
  journal={Expert Review of Clinical Pharmacology},
  year={2018},
  volume={11},
  pages={1085 - 1098}
}
  • C. Bastianelli, M. Farris, +2 authors G. Benagiano
  • Published 2018
  • Medicine
  • Expert Review of Clinical Pharmacology
    • ABSTRACT Introduction: Following a historical overview, the ovulation-inhibiting effect of various orally administered estrogen-progestin combinations (combined oral contraceptives [COCs]) are examined for their components alone or in the various combined formulations. Special emphasis is given to products containing natural estrogens. Areas covered: Inhibition of ovulation with progestins alone; estrogens alone; various progestins in combination with ethinyl estradiol; various progestins in… CONTINUE READING
    View on Taylor & Francis
    ncbi.nlm.nih.gov
    6 Citations
    Background Citations
    1
    6 Citations
    Citation Type

    Citation Type

    Pharmacodynamics of combined estrogen–progestin oral contraceptives: 4. Effects on uterine and cervical epithelia
    • 1
    Comparison of the Efficacy and Tolerability of Dienogest and Dienogest Plus Ethinylestradiol on Endometriosis Related-Pain
    • PDF
    A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy.
    Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the obstetrician's view.
    • A. James
    • Medicine
    • Hematology. American Society of Hematology. Education Program
    • 2019
    • PDF
    Current treatment for Polycystic Ovary Syndrome: focus on adolescence.
    • 1
    Contraception for the Cardiac Patient: a Cardiologist’s Primer
    • PDF

    References

    SHOWING 1-10 OF 159 REFERENCES
    Estrogens in oral contraceptives: historical perspectives.
    • 9
    Estrogens in oral contraceptives: historical perspectives.
    • 8
    Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills.
    • 111
    Pharmacological and endocrine profiles of gestodene.
    • 17
    • Highly Influential
    Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency.
    • 38
    Pharmacology of estrogens and progestogens: influence of different routes of administration
    • H. Kuhl
    • Medicine
    • Climacteric : the journal of the International Menopause Society
    • 2005
    • 436
    • PDF
    New knowledge in the physiology of hormonal contraceptives.
    • 49
    Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    • 41
    THE ROLE OF PROGESTOGENS IN THE HORMONAL CONTROL OF FERTILITY.
    • 86
    Endogenous estradiol metabolism during treatment with oral contraceptives.
    • 5